Aktis Oncology, Inc. (AKTS) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.33B and a free-cash-flow yield of -5.8%. Over the most recent reported fiscal year, revenue grew 336.9% and free cash flow per share fell 511.2%.